- EC has approved an advance purchase agreement in which the Janssen will supply 200 M doses of thw COVID-19 vaccine candidate to EU member states following approval from regulators. Additionally, the EU member states have an option to secure up to 200M additional doses
- The agreement follows the conclusion of exploratory talks with the EC. Apart from the agreement, J&J plans to allocate up to 500M vaccine doses toward international efforts for ensuring access in lower income countries, with delivery beginning in mid-2021, following approval
- J&J is evaluating a single dose regimen in P-III ENSEMBLE study initiated in Sept’2020 and plans the initiation of P-III study with two-dose regimen later this year
Click here to read full press release/ article | Ref: J&J | Image: Law.com
The post J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine first appeared on PharmaShots.